Joe Anderson, PhD

Dr. Joe Anderson is a partner at Sofinnova Partners, a leading life science venture capital firm. He has more than 30 years of experience in the health care and life science industry. Joe was a partner at Abingworth LLP, where he led venture-style investments in public companies and the formation of the firm’s public equities fund. He also cofounded and was Chief Executive Officer of Arix Biosciences plc, a venture capital business listed on the London Stock Exchange. As an investor and active board member, Joe has helped companies with financings, IPOs, and M&As, including Algeta (sold to Bayer), Amarin Corp (listed on the Nasdaq), Autolus Therapeutics plc (listed on the Nasdaq), and Cytos Biotechnology (merged with Kuros). His early career was at the Wellcome Trust, where he became head of the strategy group. Joe then moved into equities research as a pharmaceutical analyst at Dresdner Kleinwort Benson and fund management at First State Investments before moving into venture capital in 2004.